References:
1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World
Health Organization Classification of Haematolymphoid Tumours: Myeloid
and Histiocytic/Dendritic Neoplasms. Leukemia.2022;36(7):1703-1719.
2. Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. .WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues, Revised Fourth Edition. Vol 2. Lyon, France: IARC/WHO Press;
2017.
3. Weinberg OK, Arber DA. How I Diagnose Acute Leukemia of Ambiguous
Lineage. Am J Clin Pathol. 2022;158(1):27-34.
4. Liu Y, Easton J, Shao Y, et al. The genomic landscape of pediatric
and young adult T-lineage acute lymphoblastic leukemia. Nat
Genet. 2017;49(8):1211-1218.
5. Meijerink JPP. BCL11B, the Cerberus of human leukemia. Blood.2021;138(9):741-743.
6. Abbas S, Sanders MA, Zeilemaker A, et al. Integrated genome-wide
genotyping and gene expression profiling reveals BCL11B as a putative
oncogene in acute myeloid leukemia with 14q32 aberrations.Haematologica. 2014;99(5):848-857.
7. Bendig S, Stengel A, Walter W, et al. Diagnostic challenge of
identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving BCL11B
in acute leukemias of ambiguous lineage: an analysis of eight patients.Leuk Lymphoma. 2022;63(3):747-750.
8. Di Giacomo D, La Starza R, Gorello P, et al. 14q32 rearrangements
deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid
immature acute leukemia. Blood. 2021;138(9):773-784.
9. Montefiori LE, Bendig S, Gu Z, et al. Enhancer Hijacking Drives
Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.Cancer Discov. 2021;11(11):2846-2867.
10. Wang W, Beird H, Kroll CJ, et al. T(6;14)(q25;q32) involves BCL11B
and is highly associated with mixed-phenotype acute leukemia, T/myeloid.Leukemia. 2020;34(9):2509-2512.
11. Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for
children and adults with mixed phenotype acute leukemia: a systematic
review and meta-analysis. Leukemia. 2018;32(7):1515-1528.
12. Orgel E, Alexander TB, Wood BL, et al. Mixed-phenotype acute
leukemia: A cohort and consensus research strategy from the Children’s
Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.Cancer. 2020;126(3):593-601.
13. Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell
of origin of mixed phenotype acute leukaemia. Nature.2018;562(7727):373-379.
14. Cheng J, Klairmont MM, Choi JK. Peripheral blood flow cytometry for
the diagnosis of pediatric acute leukemia: Highly reliable with rare
exceptions. Pediatr Blood Cancer. 2019;66(1):e27453.
15. Rasekh EO, Osman R, Ibraheem D, et al. Acute lymphoblastic
leukemia-like treatment regimen provides better response in mixed
phenotype acute leukemia: a comparative study between adults and
pediatric MPAL patients. Ann Hematol. 2021;100(3):699-707.
16. Duffield AS, Mullighan CG, Borowitz MJ. International Consensus
Classification of acute lymphoblastic leukemia/lymphoma. Virchows
Arch. 2023;482(1):11-26.